Psychiatry and Neurology, Neurology · Davenport, IA
NPI
1821076753
Since 2005
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
4700 E 56th St, Suite 100
Davenport, IA, 52807
Phone (563) 383-2667
Groups this clinician bills Medicare through
Medicare paid, 2024
$174K
19,681 services
Medicare patients, 2024
641
Average age 73
Drug cost, 2024
$1.6M
2,174 prescriptions
Company payments, 2025
$162
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Irena M Charysz-Birski was code J0585 (injection, onabotulinumtoxina, 1 unit), 18,500 times for 26 patients. In total Irena M Charysz-Birski billed 19,681 services in 46 codes, and Medicare paid $174K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-04-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 18,500 | 26 | $4.98 | $92K |
| 95886 Electrical Nerve Conductivity | Office | 130 | 80 | $69.11 | $8,985 |
| 95800 Sleep Study | Facility | 127 | 126 | $27.47 | $3,489 |
| 95811 Sleep Study | Facility | 123 | 122 | $85.99 | $11K |
| 99214 Office E&M - Established | Office | 111 | 92 | $78.86 | $8,754 |
| 99213 Office E&M - Established | Office | 88 | 80 | $59.30 | $5,218 |
| 95874 Musculoskeletal | Office | 48 | 17 | $50.94 | $2,445 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 47 | 42 | $12.02 | $565 |
| 95810 Sleep Study | Facility | 40 | 40 | $86.64 | $3,466 |
| 95910 Electrical Nerve Conductivity | Office | 38 | 37 | $129.41 | $4,918 |
| 95819 Neurologic | Facility | 37 | 35 | $40.30 | $1,491 |
| 95909 Electrical Nerve Conductivity | Office | 36 | 36 | $93.45 | $3,364 |
| 95885 Electrical Nerve Conductivity | Office | 35 | 28 | $40.50 | $1,417 |
| 99222 Hospital E&M - Initial | Facility | 30 | 30 | $94.25 | $2,827 |
| 95816 Neurologic | Facility | 25 | 24 | $39.87 | $997 |
By year: 2022 $105K for 7,694 services; 2023 $139K for 15,159 services; 2024 $174K for 19,681 services.
Medicare prescription drug claims, 2024
In 2024, the drug Irena M Charysz-Birski prescribed most often to Medicare patients was Gabapentin, with 324 prescriptions and refills. In total Irena M Charysz-Birski wrote 2,174 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 324 | 488 | 56 | $8,658 |
| Lamotrigine Generic | 174 | 268 | 20 | $2,764 |
| Levetiracetam Generic | 128 | 263 | 29 | $3,504 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 102 | 195 | 23 | $3,755 |
| Baclofen Generic | 79 | 151 | 17 | $2,442 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 79 | 147 | 17 | $964 |
| Pregabalin Generic | 68 | 86 | Under 11 | $1,077 |
| Topiramate Generic | 56 | 100 | Under 11 | $521 |
| Sumatriptan Succinate Generic | 48 | 48 | Under 11 | $740 |
| Primidone Generic | 45 | 84 | Under 11 | $964 |
| Donepezil Hcl Generic | 41 | 73 | Under 11 | $381 |
| Memantine Hcl Generic | 39 | 59 | Under 11 | $318 |
| Tizanidine Hcl Generic | 39 | 79 | Under 11 | $3,226 |
| Pyridostigmine Bromide Generic | 38 | 58 | Under 11 | $1,425 |
| Duloxetine Hcl Generic | 36 | 66 | Under 11 | $227 |
Brand drugs: - claims; generic drugs: 1,908 claims; opioid claims: 54.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Irena M Charysz-Birski $162 ($162 in general payments such as food, travel and fees) from 4 companies. The largest payer was Abbvie Inc. with $68.41.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.